Skip to main content

Hormonal Contraceptives Market to Hit USD 24,330.1 Million by 2027; Growing Focus to Cater to Unmet Contraceptive Demand Worldwide: Fortune Business Insights™

Written by Customer Service on . Posted in Mergers And Acquisitions.

Pune, India, March 25, 2021 (GLOBE NEWSWIRE) — The global hormonal contraceptives market size is expected to showcase considerable growth by reaching USD 24,330.1 million by 2027 while exhibiting a CAGR of 5.4% between 2020 and 2027.

This information is published by Fortune Business Insights in its latest report, titled, “Hormonal Contraceptives Industry, 2020-2027.” The report further mentions that the market stood at USD 17,620.9 million in 2019 and is likely to experience considerable growth during the forecast period. This is attributable to the increasing focus on catering to the unmet demand for these contraceptives across the globe.

Increasing Focus to Cater to Unmet Contraceptive Needs to Augment Growth

According to the report by NCBI, the rate of womens’ testing positive for pregnancy if they take hormonal contraceptives properly is only 1 out of 1,000. Moreover, these contraceptives are perceived to be more reliable than sponges/diaphragms and condoms. However, the unmet needs for contraction is propelling the manufacturers to focus their strategies on such regions.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/hormonal-contraceptives-market-102078

For instance, as per World Health Organization (WHO), around 24.2% of women of reproductive age in Africa have an unmet need for modern contraception. Therefore, the growing focus on catering to the unmet demand is expected to favor the global hormonal contraceptives market growth during the forecast period.

COVID-19 Impact: Market to Exhibit -4.3% CAGR in 2020

The market is expected to go through torrid times due to the seismic effects of the pandemic. The lockdown announced by the government agencies has led to closed stores and limited availability of contraceptives. This is likely to hamper the growth prospects and the market is projected to exhibit a -4.3% CAGR in 2020.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/hormonal-contraceptives-market-102078

What does the Report Include?

The global market for hormonal contraceptives report includes detailed analysis obtained by the research analyst using several research methodologies on several factors such as the key drivers and restraints that will impact growth. Additionally, the report provides insights into the regional analysis that covers different regions, which are contributing to the growth of the market.

It includes the competitive landscape that involves the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, and collaboration that will further contribute to the market growth between 2020 and 2027.

Quick Buy – Hormonal Contraceptives Market Research Report: https://www.fortunebusinessinsights.com/checkout-page/102078

List of the Companies Profiled in the Global Market:

  • Allergan (Dublin, Ireland)
  • Merck & Co., Inc. (New Jersey, United States)
  • Janssen Pharmaceuticals, Inc. (Beerse, Belgium)
  • Teva Pharmaceutical Industries (Petah Tikva, Israel)
  • Pfizer, Inc. (New York, United States)
  • Mylan N.V. (Pennsylvania, United States)
  • Novartis AG (Basel, Switzerland)
  • Other Prominent Players

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/hormonal-contraceptives-market-102078

Some major points from Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Recent industry developments such as mergers & acquisitions
    2. regulatory scenario for key countries
    3. Fertility Statistics for Key Countries, 2018
    4. Reimbursement Scenario
    5. New Product Launches
  5. Global Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product
      1. Pills
      2. Injectable
      3. Vaginal Ring
      4. Intrauterine Device
      5. Implants
      6. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
      4. Public Channel & NGOs
      5. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Hormonal Contraceptives Industry Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Pills
      2. Injectable
      3. Vaginal Ring
      4. Intrauterine Device
      5. Implants
      6. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
      4. Public Channel & NGOs
      5. Others
    4. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. Europe Hormonal Contraceptives Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Pills
      2. Injectable
      3. Vaginal Ring
      4. Intrauterine Device
      5. Implants
      6. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
      4. Public Channel & NGOs
      5. Others
    4. Market Analysis – By Countries/ Sub-regions
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Scandinavia
      7. Rest of Europe
  8. Asia pacific Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis – By Product
      1. Pills
      2. Injectable
      3. Vaginal Ring
      4. Intrauterine Device
      5. Implants
      6. Others
    3. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Online Channel
      4. Public Channel & NGOs
      5. Others
    4. Market Analysis – By Countries/ Sub-regions
      1. Japan
      2. China
      3. India
      4. Australia
      5. Southeast Asia
      6. Rest of Asia Pacific

Continued…

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/hormonal-contraceptives-market-102078

Have a Look at Related Reports:

Medical Imaging Market Size, Share & COVID-19 Impact Analysis, Type (Magnetic Resonance Imaging, Computed Tomography, X-ray, Ultrasound and Molecular Imaging), By Application (Cardiology, Neurology, Orthopedics, Gynecology, Oncology and Others), By End User (Hospitals, Specialty Clinics, Diagnostic Imaging Centers, and Others), and Regional Forecast, 2020-2027

mHealth Apps Market Size, Share & Industry Analysis, By App Type (Disease & Treatment Management, Wellness Management, Others), By Application (Monitoring Services, Fitness Solutions, Diagnostic Services, Treatment Services, Others), By Operating System Type (Google Play Store, Apple App Store, Others) and Regional Forecast, 2019-2026

Pain Management Devices Market Size, Share and Industry Analysis By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Regional Forecast, 2019 – 2026

Diabetic Ulcer Treatment Market Size, Share and Covid-19 Impact Analysis, By Ulcer Type (Foot Ulcer (Neuropathic Ulcer, Ischemic Ulcer, and Neuro-ischemic Ulcer), Mouth Ulcer, and Others), By Treatment Type (Wound-care Dressings, Wound-care Devices, Active Therapies, and Others), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare Settings), and Regional Forecast, 2020-2027

Reading Glasses Market Size, Share & Industry Analysis, By Age Group (Less than 18 years, 18-64 years, and 65 years and above), By Type (Prescription Reading Glasses and OTC Reading Glasses), By Distribution Channel (Retail Stores, Online Sales Channels, Ophthalmol-ogy Clinics), and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.

Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release: https://www.fortunebusinessinsights.com/press-release/hormonal-contraceptives-market-9561

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.